Osaic Holdings
TRVI icon

Osaic Holdings’s Trevi Therapeutics TRVI Stock Holding History

Osaic Holdings’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.3K Buy
+1,538
New +$17.2K ﹤0.01% 5913
2021
Q1 		– Sell
-1,000
Closed -$2K – 6949
2020
Q4 		$2K Hold
1,000
– – ﹤0.01% 6114
2020
Q3 		$4K Buy
+1,000
New +$4.7K ﹤0.01% 5664

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Osaic Holdings's TRVI Position: Q1 2026 in Review

Osaic Holdings opened a new position in Trevi Therapeutics (TRVI) in Q1 2026: 1,538 shares worth $18.3K. The stake represents ﹤0.01% of the portfolio and ranks #5913 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in TRVI as recently as Q4 2020.

Osaic Holdings first reported a position in TRVI in Q3 2020 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold TRVI as of Q1 2026.

  • Osaic Holdings held 1,538 shares of Trevi Therapeutics worth $18.3K as of Q1 2026.
  • Trevi Therapeutics was a new Osaic Holdings position in Q1 2026.
  • Trevi Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5913 holding.
  • Osaic Holdings first reported a position in Trevi Therapeutics in Q3 2020 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.